Currently Unavailable
Enter your email to be notified when this product is available.
GLP-1/glucagon dual agonist. 5mg lyophilized powder per vial.
All compounds independently tested and verifiedLab results →
Mazdutide
What It Is
Mazdutide is another GLP-1/glucagon dual agonist, developed by Innovent Biologics with Eli Lilly. It became the first compound in its class to receive regulatory approval (China, 2024) for obesity. Based on the structure of oxyntomodulin — the natural dual agonist your gut releases after meals.
How It Works
Balanced GLP-1 and glucagon receptor activation. The glucagon component may help maintain metabolic rate during weight loss (the "metabolic adaptation" problem that slows weight loss over time), while GLP-1 handles appetite suppression.
What The Research Shows
GLORY-1 trial: 11.7% (4mg) and 15.6% (6mg) weight loss over 48 weeks.
First drug in its class approved anywhere in the world (China, 2024).
HbA1c reductions of 1.0–1.4% in type 2 diabetes participants.
Sources
Mazdutide for the treatment of obesity
Ji L et al. — Lancet, 2023 · PubMed
Information derived from published preclinical and clinical research. Provided for educational purposes only — not medical advice.
Customer Reviews
- Ryan K.★★★★★
Customer service is top notch and fast delivery!
- Jamie★★★★★
Had my order confirmation instantly, shipping information within hours and product delivered in 2 business days.
- Jessica T.★★★★★
Great communication when a product came back in stock and even got a free bottle of bac water!
- Sanjiv R.★★★★★
Product quality is the best and had it delivered to my office within 72 hours of ordering.